Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
EBIATShares Issued
Ratios

Forte Biosciences (FBRX) Shares Outstanding (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Shares Outstanding for 5 consecutive years, with $11.2 million as the latest value for Q3 2020.

  • Quarterly Shares Outstanding rose 432.03% to $11.2 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Sep 2020, up 432.03% year-over-year, with the annual reading at $2.1 million for FY2019, 0.0% changed from the prior year.
  • Shares Outstanding for Q3 2020 was $11.2 million at Forte Biosciences, roughly flat from $11.2 million in the prior quarter.
  • The five-year high for Shares Outstanding was $46.2 million in Q1 2017, with the low at $2.1 million in Q4 2018.
  • Average Shares Outstanding over 5 years is $12.7 million, with a median of $11.2 million recorded in 2020.
  • The sharpest move saw Shares Outstanding skyrocketed 802.72% in 2017, then tumbled 89.43% in 2019.
  • Over 5 years, Shares Outstanding stood at $2.2 million in 2016, then surged by 802.72% to $19.9 million in 2017, then plummeted by 89.4% to $2.1 million in 2018, then changed by 0.0% to $2.1 million in 2019, then surged by 432.03% to $11.2 million in 2020.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $11.2 million, $11.2 million, and $2.2 million for Q3 2020, Q2 2020, and Q1 2020 respectively.